CAMP SCHEDULE 13G: SEC filing
Filed with the SEC on · accession 0001493152-26-036926
CAMP filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 10, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -0.5% by the first close after the filing.
Summary of the filing
Trails Edge Capital Partners, LP and Trails Edge Biotechnology Master Fund, LP filed a joint Schedule 13G indicating a passive ownership position in Camp4 Therapeutics Corporation common stock.
Key details
How CAMP stock reacted
Close before
$4.24
Aug 7, 2026
First close after
-0.47%
$4.22
5 trading days
+28.30%
$5.44
Since filing
-4.25%
$4.06
✦ Ask GOAX AI about this filing — what it means for CAMP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CAMP?
Click hereFrequently asked questions
What did CAMP file with the SEC on Aug 10, 2026?
CAMP filed a SCHEDULE 13G (SEC filing). Trails Edge Capital Partners, LP and Trails Edge Biotechnology Master Fund, LP filed a joint Schedule 13G indicating a passive ownership position in Camp4 Therapeutics Corporation common stock.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did CAMP stock react to this filing?
CAMP closed at $4.24 before the filing and $4.22 on Aug 10, 2026 (-0.47%). Five trading days later: $5.44 (+28.30%).
Other CAMP SEC filings
Get alerts when CAMP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days